Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVS Health Corporation stock logo
CVS
CVS Health
$98.14
+3.1%
$78.07
$58.35
$98.22
$121.40B0.68.63 million shs12.55 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$50.42
-5.4%
$51.73
$22.28
$59.55
$21.14B1.058.09 million shs7.48 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.96
+0.3%
$27.03
$21.97
$28.75
$147.44B0.3536.72 million shs39.37 million shs
The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVS Health Corporation stock logo
CVS
CVS Health
+3.11%+12.96%+25.64%+25.95%+62.22%
Moderna, Inc. stock logo
MRNA
Moderna
-5.35%+3.34%-0.51%+25.70%+97.80%
Pfizer Inc. stock logo
PFE
Pfizer
+0.28%-2.09%-5.01%-5.50%+13.54%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVS Health Corporation stock logo
CVS
CVS Health
$98.14
+3.1%
$78.07
$58.35
$98.22
$121.40B0.68.63 million shs12.55 million shs
Moderna, Inc. stock logo
MRNA
Moderna
$50.42
-5.4%
$51.73
$22.28
$59.55
$21.14B1.058.09 million shs7.48 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.96
+0.3%
$27.03
$21.97
$28.75
$147.44B0.3536.72 million shs39.37 million shs
The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVS Health Corporation stock logo
CVS
CVS Health
+3.11%+12.96%+25.64%+25.95%+62.22%
Moderna, Inc. stock logo
MRNA
Moderna
-5.35%+3.34%-0.51%+25.70%+97.80%
Pfizer Inc. stock logo
PFE
Pfizer
+0.28%-2.09%-5.01%-5.50%+13.54%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CVS Health Corporation stock logo
CVS
CVS Health
2.85
Moderate Buy$97.00-1.17% Downside
Moderna, Inc. stock logo
MRNA
Moderna
1.84
Reduce$35.73-29.13% Downside
Pfizer Inc. stock logo
PFE
Pfizer
2.23
Hold$28.7410.72% Upside

Current Analyst Ratings Breakdown

Latest CVS, MRNA, and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/12/2026
CVS Health Corporation stock logo
CVS
CVS Health
Boost Price TargetOverweight$101.00 ➝ $111.00
5/12/2026
CVS Health Corporation stock logo
CVS
CVS Health
Boost Price TargetOutperform$94.00 ➝ $106.00
5/11/2026
CVS Health Corporation stock logo
CVS
CVS Health
Boost Price TargetBuy$105.00 ➝ $110.00
5/11/2026
CVS Health Corporation stock logo
CVS
CVS Health
Boost Price TargetBuy$105.00 ➝ $110.00
5/8/2026
CVS Health Corporation stock logo
CVS
CVS Health
Reiterated RatingHold (C)
5/8/2026
CVS Health Corporation stock logo
CVS
CVS Health
Boost Price TargetOverweight$102.00 ➝ $103.00
5/7/2026
CVS Health Corporation stock logo
CVS
CVS Health
Boost Price TargetOutperform$93.00 ➝ $107.00
5/7/2026
CVS Health Corporation stock logo
CVS
CVS Health
Boost Price TargetOverweight$93.00 ➝ $101.00
5/7/2026
CVS Health Corporation stock logo
CVS
CVS Health
Boost Price TargetBuy$97.00 ➝ $100.00
5/7/2026
CVS Health Corporation stock logo
CVS
CVS Health
Boost Price TargetBuy$98.00 ➝ $102.00
5/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
UpgradeHold (C-)Hold (C)
(Data available from 5/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CVS Health Corporation stock logo
CVS
CVS Health
$402.07B0.31$15.36 per share6.39$60.85 per share1.61
Moderna, Inc. stock logo
MRNA
Moderna
$1.94B10.29N/AN/A$18.67 per share2.70
Pfizer Inc. stock logo
PFE
Pfizer
$62.58B2.36$4.41 per share5.88$15.86 per share1.64
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CVS Health Corporation stock logo
CVS
CVS Health
$1.77B$2.2743.2411.840.930.72%11.88%3.54%7/30/2026 (Estimated)
Moderna, Inc. stock logo
MRNA
Moderna
-$2.82B-$8.15N/AN/AN/A-143.55%-26.64%-19.32%7/31/2026 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$1.3119.819.08N/A11.83%19.44%8.41%N/A

Latest CVS, MRNA, and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2026Q1 2026
CVS Health Corporation stock logo
CVS
CVS Health
$2.21$2.57+$0.36$2.30$94.99 billion$100.43 billion
5/5/2026Q1 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.7220$0.75+$0.0280$0.47$13.84 billion$14.45 billion
5/1/2026Q1 2026
Moderna, Inc. stock logo
MRNA
Moderna
-$3.02-$3.40-$0.38-$3.40$236.37 million$389.00 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
CVS Health Corporation stock logo
CVS
CVS Health
$2.662.71%+5.87%117.18%4 Years
Moderna, Inc. stock logo
MRNA
Moderna
N/AN/AN/AN/AN/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.63%-13.20%131.30%16 Years

Latest CVS, MRNA, and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/22/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.436.71%5/8/20265/8/20266/12/2026
3/18/2026
CVS Health Corporation stock logo
CVS
CVS Health
quarterly$0.66503.37%4/23/20264/23/20265/4/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CVS Health Corporation stock logo
CVS
CVS Health
0.78
0.87
0.66
Moderna, Inc. stock logo
MRNA
Moderna
0.08
2.41
2.35
Pfizer Inc. stock logo
PFE
Pfizer
0.67
1.25
0.94

Institutional Ownership

CompanyInstitutional Ownership
CVS Health Corporation stock logo
CVS
CVS Health
80.66%
Moderna, Inc. stock logo
MRNA
Moderna
75.33%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
CVS Health Corporation stock logo
CVS
CVS Health
0.85%
Moderna, Inc. stock logo
MRNA
Moderna
10.80%
Pfizer Inc. stock logo
PFE
Pfizer
0.62%
CompanyEmployeesShares OutstandingFree FloatOptionable
CVS Health Corporation stock logo
CVS
CVS Health
300,0001.28 billion1.27 billionOptionable
Moderna, Inc. stock logo
MRNA
Moderna
4,700396.79 million353.93 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable

Recent News About These Companies

Top Analyst Reports for Meta, Pfizer & Salesforce
Can Pfizer Achieve High Single-Digit Revenue CAGR From 2029?
Transcript: Valneva Q1 2026 Earnings Conference Call
Pfizer: Don't Pass On This Dirt-Cheap Buying Opportunity
How tough is it getting for vaccine makers in the U.S.?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
CVS Health stock logo

CVS Health NYSE:CVS

$98.14 +2.99 (+3.15%)
Closing price 05/13/2026 03:59 PM Eastern
Extended Trading
$97.16 -0.99 (-1.01%)
As of 04:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Moderna stock logo

Moderna NASDAQ:MRNA

$50.42 -2.85 (-5.35%)
Closing price 05/13/2026 04:00 PM Eastern
Extended Trading
$50.24 -0.18 (-0.36%)
As of 04:07 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; rare disease intracellular therapeutics; and inhaled pulmonary therapeutics. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Chiesi Farmaceutici S.p.A.; Metagenomi, Inc.; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Pfizer stock logo

Pfizer NYSE:PFE

$25.96 +0.09 (+0.33%)
Closing price 05/13/2026 03:59 PM Eastern
Extended Trading
$25.93 -0.02 (-0.10%)
As of 04:08 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.